Antidiabetic Medications and Risk of Cancer

Conditions

• Cancer

Interventions

• DRUG: Metformin
• DRUG: sulphonylurea
• DRUG: DPP-4 inhibitor
• DRUG: GLP-1 Receptor Agonists
• DRUG: SGLT-2 inhibitor
• DRUG: insulin
• DRUG: MET + SU
• DRUG: MET + DPP-4 inhibitor
• DRUG: MET + GLP-1RA
• DRUG: MET + SGLT2i
• DRUG: MET + INS

Sponsor

University of Pecs